VentriPoint Diagnostics Ltd. (CVE:VPT) Director George Adams Sells 1,525,500 Shares
VentriPoint Diagnostics Ltd. (CVE:VPT) Director George Adams sold 1,525,500 shares of the business’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of C$0.14, for a total value of C$213,570.00. Following the completion of the sale, the director now owns 43,724 shares in the company, valued at C$6,121.36.
VentriPoint Diagnostics stock traded down C$0.01 during midday trading on Thursday, reaching C$0.12. The stock had a trading volume of 106,500 shares, compared to its average volume of 186,570. VentriPoint Diagnostics Ltd. has a 12 month low of C$0.10 and a 12 month high of C$0.27. The firm’s 50-day moving average price is C$0.15 and its 200 day moving average price is C$0.15. The firm has a market capitalization of $7.57 million and a PE ratio of -2.16.
VentriPoint Diagnostics Company Profile
Featured Story: Call Option Volume
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.